Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2009
Funding of Parkinson research from industry and US federal and foundation sourcesE Ray Dorsey, Joel P Thompson, Mark Frasier, et al.Neurology|October 15, 2017
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.Nature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 27, 2016
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortUn Jung Kang, Jennifer G Goldman, Roy N Alcalay, et al.Journal of Neuroinflammation|August 20, 2017
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's diseaseLori N Eidson, George T Kannarkat, Christopher J Barnum, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2017
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerationsBrit Mollenhauer, Richard Batrla, Omar El-Agnaf, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2017
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJennifer G Goldman, Howard Andrews, Amy Amara, et al.Pageof 4